{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:40:08Z","timestamp":1767825608935,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T00:00:00Z","timestamp":1347926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGE"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11357-012-9470-2","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T11:05:59Z","timestamp":1347879959000},"page":"1675-1690","source":"Crossref","is-referenced-by-count":32,"title":["Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage"],"prefix":"10.1007","volume":"35","author":[{"given":"Ana I.","family":"Rodriguez-Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Dominguez-Meijide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Labandeira-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,18]]},"reference":[{"key":"9470_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.regpep.2004.12.027","volume":"128","author":"N Basso","year":"2005","unstructured":"Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario Lores Arnaiz M, Inserta F (2005) Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept 128:247\u2013252","journal-title":"Regul Pept"},{"key":"9470_CR2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1211\/0022357991777038","volume":"51","author":"V Ben","year":"1999","unstructured":"Ben V, Blin O, Bruguerolle B (1999) Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions. J Pharm Pharmacol 51:1405\u20131408","journal-title":"J Pharm Pharmacol"},{"key":"9470_CR3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI36703","volume":"119","author":"A Benigni","year":"2009","unstructured":"Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G (2009) Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 119:524\u2013530","journal-title":"J Clin Invest"},{"key":"9470_CR4","doi-asserted-by":"crossref","unstructured":"Benigni A, Orisio S, Noris M, Iatropoulos P, Castaldi D, Kamide K, Rakugi H, Arai Y, Todeschini M, Ogliari G, Imai E, Gondo Y, Hirose N, Mari D, Remuzzi G (2012) Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity. Age (Dordr), in press","DOI":"10.1007\/s11357-012-9408-8"},{"key":"9470_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","volume":"7","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Albin RL (2011) White matter lesions in Parkinson disease. Nat Rev Neurol 7:229\u2013236","journal-title":"Nat Rev Neurol"},{"key":"9470_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.22588","volume":"71","author":"AS Buchman","year":"2012","unstructured":"Buchman AS, Shulman JM, Nag S, Leurgans SE, Arnold SE, Morris MC, Schneider JA, Bennett DA (2012) Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol 71:258\u2013266","journal-title":"Ann Neurol"},{"key":"9470_CR7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.HYP.37.4.1141","volume":"37","author":"MA Clark","year":"2001","unstructured":"Clark MA, Diz DI, Tallant EA (2001) Angiotensin-(1\u20137) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension 37:1141\u20131146","journal-title":"Hypertension"},{"key":"9470_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2006.11.013","volume":"26","author":"TJ Collier","year":"2007","unstructured":"Collier TJ, Lipton J, Daley BF, Palfi S, Chu Y, Sortwell C, Bakay RA, Sladek JR Jr, Kordower JH (2007) Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis 26:56\u201365","journal-title":"Neurobiol Dis"},{"key":"9470_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer\u2019s disease. Prog Neurobiol 64:575\u2013611","journal-title":"Prog Neurobiol"},{"key":"9470_CR10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainresrev.2007.01.003","volume":"54","author":"E Farkas","year":"2007","unstructured":"Farkas E, Luiten PG, Bari F (2007) Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54:162\u2013180","journal-title":"Brain Res Rev"},{"key":"9470_CR11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","volume":"74","author":"KK Griendling","year":"1994","unstructured":"Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141\u20131148","journal-title":"Circ Res"},{"key":"9470_CR12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","volume":"86","author":"KK Griendling","year":"2000","unstructured":"Griendling KK, Sorescu D, Ushio-Fukai M (2000) NADPH oxidase. Role in cardiovascular biology and disease. Circ Res 86:494\u2013501","journal-title":"Circ Res"},{"key":"9470_CR13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1699-0463.1988.tb05320.x","volume":"96","author":"HJG Gundersen","year":"1988","unstructured":"Gundersen HJG, Bendsen TF, Korbo L, Marcussen N, Moller A, Nielsen K (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APIMS 96:379\u2013394","journal-title":"APIMS"},{"key":"9470_CR14","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.01270.2005","volume":"291","author":"H Hong","year":"2006","unstructured":"Hong H, Zeng JS, Kreulen DL, Kaufman DI, Chen AF (2006) Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am J Physiol Heart Circ Physiol 291:H2210\u2013H2215","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"9470_CR15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1468-1331.2006.00926.x","volume":"13","author":"K Jellinger","year":"2006","unstructured":"Jellinger K (2006) A response to The effects of vascular disease on late onset Parkinson\u2019s disease (Papapetropoulos et al.). Eur J Neurol 13(10):e1","journal-title":"Eur J Neurol"},{"key":"9470_CR16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","volume":"109","author":"B Joglar","year":"2009","unstructured":"Joglar B, Rodriguez-Pallares J, Rodr\u00edguez-Perez AI, Rey P, Guerra MJ, Labandeira-Garcia JL (2009) The inflammatory response in the MPTP model of Parkinson\u2019s disease is mediated by brain angiotensin: relevance to progression of the disease. J Neurochem 109:656\u2013669","journal-title":"J Neurochem"},{"key":"9470_CR17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-5-8","volume":"5","author":"JB Koprich","year":"2008","unstructured":"Koprich JB, Reske-Nielsen C, Mithal P, Isacson O (2008) Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. J Neuroinflammation 5:8","journal-title":"J Neuroinflammation"},{"key":"9470_CR18","first-page":"257","volume":"2","author":"JL Labandeira-Garcia","year":"2011","unstructured":"Labandeira-Garcia JL, Rodriguez-Pallares J, Villar-Cheda B, Rodr\u00edguez-Perez AI, Garrido-Gil P, Guerra MJ (2011) Aging, angiotensin system and dopaminergic degeneration in the substantia nigra. Aging Dis 2:257\u2013274","journal-title":"Aging Dis"},{"key":"9470_CR19","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.1074\/jbc.M209793200","volume":"278","author":"JM Li","year":"2003","unstructured":"Li JM, Shah AM (2003) Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 278:12094\u201312100","journal-title":"J Biol Chem"},{"key":"9470_CR20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/jn.1994.71.3.1165","volume":"71","author":"NB Mercuri","year":"1994","unstructured":"Mercuri NB, Bonci A, Johnson SW, Stratta F, Calabresi P, Bernardi G (1994) Effects of anoxia on rat midbrain dopamine neurons. J Neurophysiol 71:1165\u20131173","journal-title":"J Neurophysiol"},{"key":"9470_CR21","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/hc3801.095585","volume":"104","author":"T M\u00fcnzel","year":"2001","unstructured":"M\u00fcnzel T, Keany JF (2001) Are ACE inhibitors a \u201cmagic bullet\u201d against oxidative stress? Circulation 104:1571\u20131577","journal-title":"Circulation"},{"key":"9470_CR22","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1093\/brain\/awr233","volume":"134","author":"R Nandhagopal","year":"2011","unstructured":"Nandhagopal R, Kuramoto L, Schulzer M, Mak E, Cragg J, McKenzie J, McCormick S, Ruth TJ, Sossi V, de la Fuente-Fernandez R, Stoessl AJ (2011) Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson\u2019s disease. Brain 134:3290\u20133298","journal-title":"Brain"},{"key":"9470_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1468-1331.2003.00748.x","volume":"11","author":"S Papapetropoulos","year":"2004","unstructured":"Papapetropoulos S, Ellul J, Argyriou AA, Talelli P, Chroni E, Papapetropoulos T (2004) The effect of vascular disease on late onset Parkinson\u2019s disease. Eur J Neurol 11:231\u2013235","journal-title":"Eur J Neurol"},{"key":"9470_CR24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00109-008-0331-5","volume":"86","author":"MI Phillips","year":"2008","unstructured":"Phillips MI, de Oliveira EM (2008) Brain renin angiotensin in disease. J Mol Med 86:715\u2013722","journal-title":"J Mol Med"},{"key":"9470_CR25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","volume":"67","author":"S Przedborski","year":"1995","unstructured":"Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM (1995) Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631\u2013647","journal-title":"Neuroscience"},{"key":"9470_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jns.2006.05.026","volume":"248","author":"I Rektor","year":"2006","unstructured":"Rektor I, Rektorov\u00e1 I, Kubov\u00e1 D (2006) Vascular parkinsonism\u2013an update. J Neurol Sci 248:185\u2013191","journal-title":"J Neurol Sci"},{"key":"9470_CR27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.parkreldis.2008.02.007","volume":"15","author":"I Rektor","year":"2009","unstructured":"Rektor I, Goldemund D, Sheardov\u00e1 K, Rektorov\u00e1 I, Mich\u00e1lkov\u00e1 Z, Dufek M (2009) Vascular pathology in patients with idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord 15:24\u201329","journal-title":"Parkinsonism Relat Disord"},{"key":"9470_CR28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neurobiolaging.2006.02.018","volume":"28","author":"P Rey","year":"2007","unstructured":"Rey P, Lopez-Real A, Sanchez-Iglesias S, Mu\u00f1oz A, Soto-Otero R, Labandeira-Garcia JL (2007) Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiol Aging 28:555\u2013567","journal-title":"Neurobiol Aging"},{"key":"9470_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","volume":"31","author":"J Rodriguez-Pallares","year":"2008","unstructured":"Rodriguez-Pallares J, Rey P, Parga JA, Mu\u00f1oz A, Guerra MJ, Labandeira-Garcia JL (2008) Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis 31:58\u201373","journal-title":"Neurobiol Dis"},{"key":"9470_CR30","doi-asserted-by":"crossref","unstructured":"Rodriguez-Pallares J, Parga JA, Joglar B, Guerra MJ, Labandeira-Garcia JL (2012) Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson\u2019s disease. Age (Dordr) 34:863\u201380","DOI":"10.1007\/s11357-011-9284-7"},{"key":"9470_CR31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.expneurol.2010.05.015","volume":"224","author":"AI Rodriguez-Perez","year":"2010","unstructured":"Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Lanciego JL, Labandeira-Garcia JL (2010) Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson\u2019s disease. Exp Neurol 224:517\u2013526","journal-title":"Exp Neurol"},{"key":"9470_CR32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/brain\/awr320","volume":"135","author":"AI Rodriguez-Perez","year":"2012","unstructured":"Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Labandeira-Garcia JL (2012) Different dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats. Role of the brain angiotensin system. Brain 135:124\u2013138","journal-title":"Brain"},{"key":"9470_CR33","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/01.ATV.0000035392.38687.65","volume":"22","author":"U Rueckschloss","year":"2002","unstructured":"Rueckschloss U, Quinn MT, Holtz J, Morawietz H (2002) Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22:1845\u20131851","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9470_CR34","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/hy1201.100589","volume":"38","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J (2001) Role of the renin-angiotensin system in vascular diseases. Expanding the field. Hypertension 38:1382\u20131387","journal-title":"Hypertension"},{"key":"9470_CR35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","volume":"59","author":"H Sauer","year":"1994","unstructured":"Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunohistochemical study in the rat. Neuroscience 59:401\u2013415","journal-title":"Neuroscience"},{"issue":"6","key":"9470_CR36","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1460-9568.2007.05781.x","volume":"26","author":"V Singh","year":"2007","unstructured":"Singh V, Carman M, Roeper J, Bonci A (2007) Brief ischemia causes long-term depression in midbrain dopamine neurons. Eur J Neurosci 26(6):1489\u20131499","journal-title":"Eur J Neurosci"},{"key":"9470_CR37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bjp.0703566","volume":"131","author":"HY Sohn","year":"2000","unstructured":"Sohn HY, Raff U, Hoffmann A, Gloe T, Heermeier K, Galle J, Pohl U (2000) Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br J Pharmacol 131:667\u2013672","journal-title":"Br J Pharmacol"},{"key":"9470_CR38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ageing\/afi025","volume":"34","author":"B Thanvi","year":"2005","unstructured":"Thanvi B, Lo N, Robinson T (2005) Vascular parkinsonism\u2013an important cause of parkinsonism in older people. Age Ageing 34:114\u2013119","journal-title":"Age Ageing"},{"key":"9470_CR39","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.RES.0000020404.01971.2F","volume":"14","author":"RM Touyz","year":"2002","unstructured":"Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL (2002) Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries, regulation by angiotensin II. Circ Res 14:1205\u20131213","journal-title":"Circ Res"},{"key":"9470_CR40","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/NEN.0b013e3181fa0308","volume":"69","author":"R Valenzuela","year":"2010","unstructured":"Valenzuela R, Barroso-Chinea P, Mu\u00f1oz A, Joglar B, Villar-Cheda B, Lanciego JL, Labandeira-Garcia JL (2010) Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death. J Neuropathol Exp Neurol 69:1130\u20131142","journal-title":"J Neuropathol Exp Neurol"},{"key":"9470_CR41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jcbfm.2008.127","volume":"29","author":"B Villar-Cheda","year":"2009","unstructured":"Villar-Cheda B, Sousa-Ribeiro D, Rodriguez-Pallares J, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2009) Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson\u2019s disease. J Cereb Blood Flow Metab 29:230\u2013234","journal-title":"J Cereb Blood Flow Metab"},{"key":"9470_CR42","doi-asserted-by":"crossref","first-page":"204.e1-11","DOI":"10.1016\/j.neurobiolaging.2010.08.006","volume":"33","author":"B Villar-Cheda","year":"2012","unstructured":"Villar-Cheda B, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL (2012) Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. Neurobiol Aging 33:204.e1-11","journal-title":"Neurobiol Aging"},{"key":"9470_CR43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","volume":"95","author":"JW Wright","year":"2011","unstructured":"Wright JW, Harding JW (2011) Brain renin-angiotensin\u2013a new look at an old system. Prog Neurobiol 95:49\u201367","journal-title":"Prog Neurobiol"},{"key":"9470_CR44","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"D Wu","year":"2003","unstructured":"Wu D, Teisman P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u00a8s disease. Proc Natl Acad Sci USA 100:6145\u20136150","journal-title":"Proc Natl Acad Sci USA"},{"key":"9470_CR45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","volume":"19","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Daniel SE, Hughes AJ, R\u00e9v\u00e9sz T, Lees AJ (2004a) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630\u2013640","journal-title":"Mov Disord"},{"key":"9470_CR46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/jnnp.2003.018309","volume":"75","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ (2004b) The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 75:545\u2013547","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9470_CR47","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/mds.21479","volume":"22","author":"J Zijlmans","year":"2007","unstructured":"Zijlmans J, Evans A, Fontes F, Katzenschlager R, Gacinovic S, Lees AJ, Costa D (2007) [123I] FP-CIT spect study in vascular parkinsonism and Parkinson\u2019s disease. Mov Disord 22:1278\u20131285","journal-title":"Mov Disord"}],"container-title":["AGE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-012-9470-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11357-012-9470-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-012-9470-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:27:22Z","timestamp":1562200042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11357-012-9470-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,18]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9470"],"URL":"https:\/\/doi.org\/10.1007\/s11357-012-9470-2","relation":{},"ISSN":["0161-9152","1574-4647"],"issn-type":[{"value":"0161-9152","type":"print"},{"value":"1574-4647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,18]]}}}